Almost $10 million funding boost for InsideOut Institute for eating disorders
On Sunday, February 3, the New South Wales Government pledged $9.6 million over the ensuing four years to a dynamic national eating disorders institute. The InsideOut Institute – Australia’s first national body for research and clinical excellence in eating disorders – was the worthy recipient of the government funds. According to Psychologist and InsideOut Institute…
Fasting to fight addiction in Australia’s youth
January has ticked over into February, bringing about the annual febfast theoretical diet pilgrimage. Established at as a fundraiser for young disadvantaged Australians, the goal is to cease sugar, alcohol or any of your other vices for one month. We’re well aware from past projects that addiction is a cruel beast. Those who find themselves…
Fasting to fight addiction in Australia’s youth
January has ticked over into February, bringing about the annual febfast theoretical diet pilgrimage. Established at as a fundraiser for young disadvantaged Australians, the goal is to cease sugar, alcohol or any of your other vices for one month. We’re well aware from past projects that addiction is a cruel beast. Those who find themselves…
Skin cancer hijacks immune system to spread toxic cells
Scientists have identified the role of skin cancer molecules and their role in hijacking healthy immune cells to help cancer spread and grow. Experts believe by targeting these molecules with inhibiting drugs, aggressive skin cancer could be prevented from returning after treatment. The findings of the Cancer Research UK-funded study were published in the journal Cell this…
APNA re-appoints Dr Tony Hobbs to Board
Team VIVA! wishes to congratulate the Australian Primary Health Care Nurses Association (APNA) for reappointing Dr Tony Hobbs to their Board today (February 1, 2019). Dr Hobbs served on the APNA board in 2011 and 2012 respectively. He most recently served as Deputy Chief Medical Officer for the Commonwealth Department of Health. He was previously…
February is Ovarian Cancer Awareness Month
Ovarian cancer is the deadliest women’s cancer. Each day, four Australian women are diagnosed with ovarian cancer and each day, it claims the lives of three women. This February is Ovarian Cancer Awareness Month and Ovarian Cancer Australia (OCA) says it’s time to ovary-act. There is an urgent need to improve survival rates and increase ovarian…
Former NRL Player, Dan Hunt reinforces the importance of living a purposeful life to Team VIVA!
At our recent annual workshop staged at Lilianfels Resort & Spa, Blue Mountains, NSW between 17-18 January, 2019, we reflected on our PR agency’s achievements over the past year and discussed strategies to enable us to move forward in 2019. During our workshop, former NRL star and guest speaker, Dan Hunt, 32, took us on…
The do’s and don’ts of office productivity
Do embrace a collaborative and diverse workplace culture Organisations that succeed display strength of combined diverse expertise by harnessing each team member’s strength to boost productivity. Let everyone’s true colours shine. Let the creatives be creative and lets the nerds be the nerds. If everyone had the exact same skill set, the potential output of…
Researchers uncover the effects of aroma on making food selections
An American research team have uncovered the effect of aroma when people make the selection between healthy and unhealthy food. Researchers from the marketing department at the University of South Florida in Tampa set out to understand how food-related ambient scents affected food choices. The team found people exposed to an unhealthy food aroma for…
Federal Health Minister announces Feb 1 PBS listing of psoriasis biologic, ILUMYA
A targeted biologic for the estimated 19,000 Australian adults living with severe chronic plaque psoriasis will be listed on the PBS from February 1, 2019. Federal Health Minister, The Hon. Greg Hunt, MP, announced the PBS listing of Sun Pharma’s ILUMYA (tildrakizumab) today, for those who meet the reimbursement criteria. ILUMYA belongs to a new class…